EMLA crème 5 % tb 30 g

7680468500330 CH-46850 N01BB20 01.02.2.

Active substances:

EMLA crème 5 % tb 30 g
EMLA crème 5 % tb 30 g
EMLA crème 5 % tb 30 g
1 / 3
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
4685001
CPT
-
Packaging group
1 x 30
Unit
g
Composition
lidocainum 25 mg, prilocainum 25 mg, macrogol 54 glyceroli hydroxystearas 19 mg, carbomerum 974P, natrii hydroxidum, aqua purificata ad unguentum pro 1 g.

Articles (1)

Emla, Creme
Creme
1 x 30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
27/10/2025
Professional SmPC
Français
27/10/2025
Professional SmPC
Italien
27/10/2025
Patient information leaflet
Allemand
12/09/2025
Patient information leaflet
Français
12/09/2025
Patient information leaflet
Italien
12/09/2025

Detailed composition

Substance Quantity Type Category
lidocainum
25.0 MG Substance Wirkstoff (Principe actif)
prilocainum
25.0 MG Substance Wirkstoff (Principe actif)
macrogol 54 glyceroli hydroxystearas
19.0 MG Substance HBESI
carbomerum 974P
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
aqua purificata
- Substance HNIDK

Authorization holder

Aspen Pharma Schweiz GmbH

6340 Baar

Authorization information

Swissmedic authorization number
46850
Drug name
Emla, Creme
Galenic form
CREM
ATC Code
N01BB20
Authorization status
Z
Dispensation category
B
First authorization
24/06/1985
Authorization expiration date
31/12/9999
IT number
01.02.2.
Domain
Human medicine
Field of application
Anästhesie der Haut

Packaging details

Description (FR)
EMLA crème 5 % tb 30 g
Description (DE)
EMLA Creme 5 % Tb 30 g
Market launch
24/06/1985
Narcotic (BTM)
No

Available generics

Prilid Leman patch, emplâtre médicamenteux
CHF 12.80
View
Prilid Leman patch, emplâtre médicamenteux
CHF 52.30
View

Other packaging sizes

EMLA crème 5 % 5 tb 5 g
5 x 5 G
View
Buy us a coffee Explore the data